X0609 4 2026-09-14 0002066836 Conexeu Sciences Inc. CNXU 0002127816 Sharpe Jeffrey Nathan false 50 WEST LIBERTY STREET, SUITE 880 RENO NV 89501 1 0 0 0 0 Common Stock 2026-09-14 4 M 0 500000 0.001 A 1500000 D Performance Warrants 0.001 2026-09-14 4 M 0 500000 0.00 D 2030-06-05 Common Stock 500000 500000 D The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act. The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed, which have vested; and (ii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration. /s/ Jefferey Sharpe 2026-09-15